Giulio Francolini

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

Luca Triggiani, Filippo Alongi, Michela Buglione et al. · British Journal of Cancer · 2017 · 147 citations · Full text

Medicine, Oncology, Urology +17

Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy

Elise De Bleser, Barbara Alicja Jereczek‐Fossa, Thomas Zilli et al. · European Urology · 2019 · 139 citations · Full text

Medicine, Oncology, Urology +17

Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)

Giulio Francolini, Andrea Gaetano Allegra, Beatrice Detti et al. · Journal of Clinical Oncology · 2023 · 126 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini et al. · World Journal of Urology · 2019 · 98 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness

Rosario Mazzola, Giulio Francolini, Luca Triggiani et al. · Clinical Genitourinary Cancer · 2020 · 78 citations

Medicine, Oncology, Radiation Oncology +17